Twitter Inc sued Elon Musk for violating the $44 billion deal to buy the social media platform in a Delaware court, demanding that the world's richest person complete the merger at the agreed $54.20 per Twitter share.
According to the filing, Musk believes that he is free to change his mind, trash the company, disrupt its operations, destroy stockholder value, and walk away.
Musk announced the termination of the agreement on Friday, claiming that Twitter had broken the terms by refusing to provide information on phony or spam accounts on the platforms, which is essential to the operation of its business.
The complaint charged Musk with breaking a long list of merger agreement provisions that "have soured Twitter and its operations."
Musk said the absence of information concerning spam accounts and erroneous claims that he claimed amounted to a "material adverse event" and management departures amounted to a failure to do business in the normal course, as Twitter was required to do, were the reasons he was canceling the merger.
Twitter said that it negotiated to have language that would have considered such firings to be outside of the ordinary course of business removed from the merger agreement.


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
South Korea Factory Output Misses Forecasts in November Amid Ongoing Economic Uncertainty
Oil Prices Slip Slightly as Markets Weigh Geopolitical Risks and Supply Glut Concerns
Democratic Attorneys General Sue Trump Administration Over Proposed Limits on Gender-Affirming Care for Youth
Bolsonaro Undergoes Phrenic Nerve Block Procedure After Surgery-Related Complications
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
DOJ Releases New Epstein Files Detailing Alleged Trump Flights on Private Jet
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
U.S. Government Agrees to Review Frozen NIH Diversity Research Grants After Legal Challenge
Federal Appeals Court Allows Trump’s National Guard Deployment in Washington, D.C. to Continue
U.S. Dollar Steadies Ahead of Fed Minutes as Markets Eye Policy Divisions
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 



